Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis.

作者: G. Gu , T. A. Hentunen , M. Nars , P. L. Härkönen , H. K. Väänänen

DOI: 10.1007/S10495-005-1893-0

关键词:

摘要: Glucocorticoid-induced osteoporosis may be at least in part due to the increased apoptosis of osteocytes. To study role osteocyte glucocorticoid-induced osteoporosis, we isolated primary osteocytes from murine calvaria for analysis effects dexamethasone vitro culture. The cells were identified by morphology, cytochemical staining, immunocytochemical staining and mRNA expression phosphate-regulating gene with homology endopeptidases on X chromosome (PHEX) sclerosteosis/van Buchem disease (SOST). We found that induced a dose-dependent manner. A glucocorticoid receptor antagonist, mifepristone (RU486), suppressed dexamethasone-induced apoptosis, suggesting it was mediated receptor. Immunocytochemical stainings showed receptors are present osteocytes, they translocated nuclei after exposure dexamethasone. Addition estrogen prevented translocation into nuclei. Corresponding antiapoptotic also seen pretreatment picomolar concentration estrogen. pure antiestrogen ICI 182,780 inhibited effect These data suggest play an important apoptosis. Most importantly, has protective {against osteocyte}{ }{apoptosis}. conclude, mechanism which can opposed

参考文章(60)
Holger M. Reichardt, François Tronche, Stefan Berger, Christoph Kellendonk, Günther Schütz, New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting. Advances in pharmacology. ,vol. 47, pp. 1- 21 ,(1999) , 10.1016/S1054-3589(08)60108-8
K. H. Väänänen, P. L. Härkönen, Bone Effects of Glucocorticoid Therapy Ernst Schering Research Foundation workshop. pp. 55- 64 ,(2002) , 10.1007/978-3-662-04660-9_4
Robert H. Oakley, Madhabananda Sar, John A. Cidlowski, The Human Glucocorticoid Receptor β Isoform: EXPRESSION, BIOCHEMICAL PROPERTIES, AND PUTATIVE FUNCTION (∗) Journal of Biological Chemistry. ,vol. 271, pp. 9550- 9559 ,(1996) , 10.1074/JBC.271.16.9550
L. C. Scherrer, S. S. Simons, E. R. Sanchez, W. B. Pratt, J. M. Harmon, M. Hirst, M. J. Welsh, G. M. Ringold, Hsin-Yi Tang, Hormone-free mouse glucocorticoid receptors overexpressed in Chinese hamster ovary cells are localized to the nucleus and are associated with both hsp70 and hsp90 Journal of Biological Chemistry. ,vol. 265, pp. 20123- 20130 ,(1990) , 10.1016/S0021-9258(17)30478-7
Robert S. Weinstein, Glucocorticoid-induced osteoporosis. Reviews in Endocrine & Metabolic Disorders. ,vol. 2, pp. 65- 73 ,(2001) , 10.1023/A:1010007108155
Michael Schmidt, Norbert Lügering, Andreas Lügering, Hans-Gerd Pauels, Klaus Schulze-Osthoff, Wolfram Domschke, Torsten Kucharzik, Role of the CD95/CD95 Ligand System in Glucocorticoid-Induced Monocyte Apoptosis The Journal of Immunology. ,vol. 166, pp. 1344- 1351 ,(2001) , 10.4049/JIMMUNOL.166.2.1344
Siân Beavan, Alan Horner, Sharyn Bord, Deborah Ireland, Juliet Compston, Colocalization of Glucocorticoid and Mineralocorticoid Receptors in Human Bone Journal of Bone and Mineral Research. ,vol. 16, pp. 1496- 1504 ,(2001) , 10.1359/JBMR.2001.16.8.1496
R. T. Turner, G. L. Evans, H. Dobnig, The high-affinity estrogen receptor antagonist ICI 182,780 has no effect on bone growth in young male rats. Calcified Tissue International. ,vol. 66, pp. 461- 464 ,(2000) , 10.1007/S002230010092
Thomas J. Hefley, Utilization of FPLC-purified bacterial collagenase for the isolation of cells from bone. Journal of Bone and Mineral Research. ,vol. 2, pp. 505- 516 ,(2009) , 10.1002/JBMR.5650020607
Barbara P. Lukert, Bruce E. Johnson, Ralph G. Robinson, Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss Journal of Bone and Mineral Research. ,vol. 7, pp. 1063- 1069 ,(2009) , 10.1002/JBMR.5650070909